Introduction: Treatment of Gram-positive infections

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue SUPPL. 2, 2003, Pages

  Wise, Richard ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; FLUCLOXACILLIN; GLYCOPEPTIDE; LINEZOLID; MACROLIDE; METICILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE POSITIVE STAPHYLOCOCCUS; COST BENEFIT ANALYSIS; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG USE; EDITORIAL; ENTEROCOCCUS; GEOGRAPHIC DISTRIBUTION; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS;

EID: 0037764024     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Fridkin, S. K. & Gaynes, R. P. (1999). Antimicrobial resistance in intensive care units. Clinics in Chest Medicine 20, 303-16.
2. Vincent, J.-L. (2000). Microbial resistance: lessons from the EPIC study. Intensive Care Medicine 26, Suppl. 4, S3-8.
3. Vincent, J.-L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M.-H. et al. for the EPIC International Advisory Committee. (1995). The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Journal of the American Medical Association 274, 639-44.
4. European Antimicrobial Resistance Surveillance System. (2000). EARSS Newsletter No. 2 (April), 1-8.
5. Kollef, M. H., Sherman, G., Ward, S. & Fraser, V. J. (1999). Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115, 462-74.
6. Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J. & Kollef, M. H. (2000). The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118, 146-55.
7. Kollef, M. H. & Ward, S. (1998). The influence of Mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113, 412-20.